The role of interleukin 17 in cancer: a systematic review
Carcinogenesis · 20.01.2025 · 46 (1)
DOI: 10.1093/carcin/bgae079 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Carcinogenesis, online erschienen am 14.12.2024. Verfasst von Emir Begagic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Cantonal Hospital Zenica, Crkvice 67, 72000 Zenica, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Interleukin-17, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 133 Literaturangaben.
Abstract (Originalsprache)
Interleukin 17 (IL17) is a cytokine involved in immune regulation and has been increasingly recognized for its role in cancer progression. This systematic review aims to integrate data on IL17’s role in various tumors to better understand its implications for cancer prognosis and treatment. The review included 105 studies (27.6% experimental and 72.4% clinical). Clinical studies involved 9266 patients: 31.2% males, 60.0% females, and 8.8% with undefined gender. IL17A and IL17 were the most studied subtypes (36.2% and 33.3%, respectively). Breast cancer (26.7%), colorectal carcinoma (13.3%), and hematologic malignancies (10.5%) were the most researched neoplasms. IL17A promoted tumor growth in breast cancer and correlated with poor outcomes in colorectal, breast, and lung cancers. IL17 also played a significant role in immune modulation in gliomas and other tumors. IL17A significantly influences tumor growth and prognosis across various cancers, with notable roles in immune modulation and poor outcomes in multiple cancer types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Cantonal Hospital Zenica, Crkvice 67, 72000 Zenica, Bosnia and Herzegovina.
- Department of Pathology, College of Medicine, QU Health, Qatar University, PO Box 2713, Doha, Qatar.
- Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, PO Box 2713, Doha, Qatar.
ORCID-Profile: Semir Vranic
Zitieren
APA
Begagic, E., Vranic, S., & Sominanda, A. (2025). The role of interleukin 17 in cancer: a systematic review. Carcinogenesis, 46(1). https://doi.org/10.1093/carcin/bgae079
Vancouver
Begagic E, Vranic S, Sominanda A. The role of interleukin 17 in cancer: a systematic review. Carcinogenesis. 2025;46(1). doi:10.1093/carcin/bgae079
BibTeX
@article{Begagic2025,
author = {Begagic, Emir and Vranic, Semir and Sominanda, Ajith},
title = {The role of interleukin 17 in cancer: a systematic review},
journal = {Carcinogenesis},
year = {2025},
volume = {46},
number = {1},
doi = {10.1093/carcin/bgae079}
}
EUVIMED